Litcius/Paper detail

Oxidized glutathione reverts carbapenem resistance in blaNDM-1-carrying Escherichia coli

Dongyang Ye, Xiaowei Li, Liang Zhao, Saiwa Liu, Xixi Jia, Zhinan Wang, Jingjing Du, Lirui Ge, Jianzhong Shen, Xi Xia

2024EMBO Molecular Medicine13 citationsDOIOpen Access PDF

Abstract

Abstract The emergence of drug-resistant Enterobacteriaceae carrying plasmid-mediated β-lactamase genes has become a significant threat to public health. Organisms in the Enterobacteriaceae family containing New Delhi metallo-β-lactamase‑1 (NDM-1) and its variants, which are capable of hydrolyzing nearly all β-lactam antibacterial agents, including carbapenems, are referred to as superbugs and distributed worldwide. Despite efforts over the past decade, the discovery of an NDM-1 inhibitor that can reach the clinic remains a challenge. Here, we identified oxidized glutathione (GSSG) as a metabolic biomarker for bla NDM-1 using a non-targeted metabolomics approach and demonstrated that GSSG supplementation could restore carbapenem susceptibility in Escherichia coli carrying bla NDM-1 in vitro and in vivo. We showed that exogenous GSSG promotes the bactericidal effects of carbapenems by interfering with intracellular redox homeostasis and inhibiting the expression of NDM-1 in drug-resistant E. coli . This study establishes a metabolomics-based strategy to potentiate metabolism-dependent antibiotic efficacy for the treatment of antibiotic-resistant bacteria.

Topics & Concepts

Escherichia coliEnterobacteriaceaeMicrobiologyAntibioticsGlutathioneCarbapenemBacteriaBiologyCarbapenem-resistant enterobacteriaceaePlasmidDrug resistanceBiochemistryGeneEnzymeGeneticsAntibiotic Resistance in BacteriaPharmaceutical and Antibiotic Environmental ImpactsAntibiotics Pharmacokinetics and Efficacy
Oxidized glutathione reverts carbapenem resistance in blaNDM-1-carrying Escherichia coli | Litcius